Insider Buying at Prenetics Global, Venu Holding, and CTT Pharmaceutical
Form 4 filings show Prenetics' CEO buying across three trades, Venu Holding's CEO/Chairman adding shares, and CTT Pharmaceutical's CEO with a small purchase.
SEC Form 4 insider-buying trackers and after-hours 8-K filing recaps — grounded in what companies actually filed, not predictions.
Form 4 filings show Prenetics' CEO buying across three trades, Venu Holding's CEO/Chairman adding shares, and CTT Pharmaceutical's CEO with a small purchase.
Five 8-Ks filed after Thursday's close: Amylyx and Nexalin priced stock offerings, Tredegar added a director, First Business posted investor slides, and Oxford Square reported vote results.
Five Form 8-K filings from August 20, 2026: a Capital One preferred stock redemption, Hovnanian's preliminary Q3 results, an Exyn CEO transition, an FHLB Dallas debt disclosure, and a Stone Point fund share sale.
Review of recent insider purchases from Form 4 filings showing activity by officers/directors and significant investors.
Summary of recent insider purchases at Latigo Biotherapeutics and AdaptHealth Corp. as reported by SEC Form 4 filings.
Form 4 filings this week show Navios Maritime Partners' CEO buying on three straight trading days, a Landmark Bancorp director adding shares, and Redmile Group building a position in Attovia Therapeutics.
Five 8-Ks filed within minutes of each other after the August 7, 2026 close: a SPAC's confidential S-4 filing, a director resignation, executive severance amendments, and two Reg FD disclosures.
Two 8-K filings from Friday afternoon, both filed within the last hour of business — a General Dynamics board appointment and a $600 million OneMain Holdings notes offering.
Summary of SEC Form 8-K filings by USA Rare Earth Inc., Uranium Royalty Corp., AIxCrypto Holdings, Inc., Microvast Holdings, and MGP Ingredients Inc. detailing significant corporate events.